Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 31, 2024

SELL
$26.13 - $33.94 $14,502 - $18,836
-555 Reduced 6.68%
7,755 $223,000
Q3 2023

Oct 13, 2023

SELL
$32.09 - $37.51 $188,528 - $220,371
-5,875 Reduced 41.42%
8,310 $275,000
Q2 2023

Jul 13, 2023

SELL
$36.12 - $41.79 $217,984 - $252,202
-6,035 Reduced 29.85%
14,185 $520,000
Q1 2023

Apr 20, 2023

SELL
$39.39 - $51.28 $16,149 - $21,024
-410 Reduced 1.99%
20,220 $824,000
Q3 2022

Oct 26, 2022

BUY
$43.76 - $53.42 $63,452 - $77,459
1,450 Added 7.56%
20,630 $903,000
Q1 2022

Apr 14, 2022

BUY
$45.75 - $56.69 $263,657 - $326,704
5,763 Added 42.95%
19,180 $993,000
Q3 2021

Nov 09, 2021

BUY
$39.25 - $50.42 $337,824 - $433,964
8,607 Added 178.94%
13,417 $577,000
Q3 2021

Nov 03, 2021

SELL
$39.25 - $50.42 $336,647 - $432,452
-8,577 Reduced 64.07%
4,810 $541,000
Q2 2021

Jul 16, 2021

BUY
$35.91 - $40.68 $8,618 - $9,763
240 Added 1.83%
13,387 $524,000
Q2 2020

Jul 31, 2020

SELL
$30.12 - $36.54 $7,530 - $9,135
-250 Reduced 1.87%
13,147 $430,000
Q2 2019

Jul 30, 2019

BUY
$36.98 - $41.52 $13,867 - $15,570
375 Added 2.88%
13,397 $577,000
Q1 2019

Apr 30, 2019

BUY
$37.5 - $41.2 $10,312 - $11,330
275 Added 2.16%
13,022 $553,000
Q4 2018

Jan 24, 2019

SELL
$38.47 - $43.86 $2,885 - $3,289
-75 Reduced 0.58%
12,747 $556,000
Q3 2018

Oct 17, 2018

SELL
$34.47 - $41.81 $861 - $1,045
-25 Reduced 0.19%
12,822 $565,000
Q2 2018

Jul 27, 2018

BUY
$32.98 - $35.16 $3,297 - $3,515
100 Added 0.78%
12,847 $466,000
Q1 2018

Apr 27, 2018

SELL
$31.91 - $37.02 $10,849 - $12,586
-340 Reduced 2.6%
12,747 $452,000
Q4 2017

Jan 19, 2018

SELL
$33.26 - $35.29 $7,816 - $8,293
-235 Reduced 1.76%
13,087 $474,000
Q3 2017

Oct 23, 2017

BUY
$31.0 - $34.15 $412,982 - $454,946
13,322
13,322 $476,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $148B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Bender Robert & Associates Portfolio

Follow Bender Robert & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bender Robert & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Bender Robert & Associates with notifications on news.